NextPlat Corp (NASDAQ:NXPL – Get Free Report) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 54,000 shares, an increase of 1,762.1% from the November 30th total of 2,900 shares. Based on an average daily trading volume, of 119,400 shares, the short-interest ratio is currently 0.5 days. Currently, 0.4% of the shares of the company are sold short.
NextPlat Stock Performance
NextPlat stock traded up $0.07 during trading hours on Thursday, hitting $1.19. The company had a trading volume of 107,337 shares, compared to its average volume of 277,754. NextPlat has a one year low of $0.71 and a one year high of $2.68. The firm has a market cap of $30.86 million, a PE ratio of -1.75 and a beta of 0.85. The firm has a 50-day moving average of $1.03 and a 200 day moving average of $1.13. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.70 and a quick ratio of 3.04.
Institutional Trading of NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Omnia Family Wealth LLC purchased a new stake in NextPlat Corp (NASDAQ:NXPL – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned 0.49% of NextPlat at the end of the most recent quarter. Institutional investors and hedge funds own 1.30% of the company’s stock.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Featured Stories
- Five stocks we like better than NextPlat
- 3 Small Caps With Big Return Potential
- Top 3 Investment Themes to Watch for in 2025
- What Are Dividend Achievers? An Introduction
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Trading Halts Explained
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.